Kineta (KANT) 10-Q2018 Q2 Quarterly report

Filed: 8 Aug 18, 4:15pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: appointed, baseline, behavior, Bentley, blood, bluebird, career, climate, consolidated, CPA, Danforth, entirety, Exhibit, GDPR, glucose, greatly, herewith, hour, hyperglycemic, index, joining, led, Lybrand, Nonemployee, olacaftor, recast, retention, Sandra, Shelia, Syndax, VP, whichever, Zimmerman

Removed: approximate, assumed, Boudreau, calculate, collateralizing, computed, corroborated, declared, deposit, discounted, dividing, equal, estimating, group, Helen, identical, intensify, IPO, marketable, mature, maturity, month, quoted, receivable, Sheila, supported, twelve, unobservable, warrant, weighted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

KANT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.5

80 Guest Street, Fifth Floor

Boston, MA 02135

August 3, 2018

PERSONAL AND CONFIDENTIAL

Sandra Zimmerman

c/o Proteostasis Therapeutics, Inc.

80 Guest Street, 5th Floor

Boston, MA 02135

Dear Ms. Zimmerman:

Proteostasis Therapeutics, Inc. (the "Company" ) is pleased to offer you the position of Principal Financial Officer to the Company, effective August 6, 2018.

The terms of this offer letter shall supplement those in the Consulting Agreement by and between the Company and Danforth Advisors, LLC, a Massachusetts limited liability corporation, dated May 7, 2018 (the "Consulting Agreement") and nothing in this offer letter will amend, modify or supersede the Consulting Agreement.

Your engagement as Principal Financial Officer will continue at the pleasure of the Board of Directors.

This offer letter may be signed in one or more counterparts.

We are excited about the prospect of having you serve as Principal Financial Officer to the Company. We look forward to receiving a response from you, acknowledging by signing below, that you have accepted this offer.

Sincerely,

PROTEOSTASIS THERAPEUTICS, INC.

By:		/s/ Meenu Chhabra
		Meenu Chhabra
		President & CEO

ACCEPTED AND AGREED ON THE DATE SET FORTH BELOW:

By:		/s/ Sandra Zimmerman
		Sandra Zimmerman

Date: August 3, 2018

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.